Spl-image-01-structure.jpg (Spl Image 01 Structure)
Molecular formula of the compound is CrzHi1CIN,055 with a molecular weight of 330.74.*
Furosemide Injection, Solution
Product Images NDC 36000-282
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 36000-282). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Spl-image-02-2ml-5pk (Spl Image 02 2ml 5pk)
Spl-image-03-4ml-5pk (Spl Image 03 4ml 5pk)
AIN00223 is a prescription medication containing Furosemide and water for injection. The solution also includes Sodium Chloride for isotonicity, Sodium Hydroxide, and Hydrochloric Acid for pH adjustment. The medication comes as a single-dose vial intended for intravenous or intramuscular use only. Unused portions need to be discarded immediately, and the solution should only be used if clear and colorless. The medication should be protected from light and stored between 20°C to 25°C (66°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The package insert provides directions for use. The medication is manufactured for Baxter Healthcare Corporation in Deerfeld, USA, by Baxter Pharmaceuticals India Pvt Ltd. Exp. date is not available.*
Spl-image-04-10ml-5pk (Spl Image 04 10ml 5pk)
This is a description of Furosemide Injection USP, which is a medication that is administered intravenously or intramuscularly. It is contained in a single-dose vial that contains 100mg of medication in 10mL of solution. The medication is manufactured by Baxter Healthcare Corporation, located in Deerfield, IL. The solution contains Furosemide along with water, sodium chloride for isotonicity, and Sodium Hydroxide, and Hydrochloric Acid are used to adjust pH above 80 and below 9.3. There are storage directions provided, including warnings to discard unused portions and to use only if the solution is clear and colorless. This text is primarily prescribing information about the medication, including the directions for use and storage guidelines.*
Spl-image-05-2ml-25pk (Spl Image 05 2ml 25pk)
This is a warning label for a medical product, with the NDC code 36000-282-25. The product is a solution with a concentration of 20mg/2mL and is intended for intravenous or intramuscular use. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with permitted excursions of 15°C to 30°C (59°F to 86°F). The package insert should be consulted for directions on how to use the product. The vials are single-use and any unused portion should be discarded. The manufacturer is Baxter Healthcare Corporation and the expiry date of the product is February 24, 2020.*
Spl-image-06-4ml-25pk (Spl Image 06 4ml 25pk)
AIN00221 is a single dose vial of Furosemide injection, manufactured by Baxter Healthcare Corporation. It has a concentration of 10mg of Furosemide per mL of water for injection. It is to be used for intravenous or intramuscular administration and should be discarded if the solution is not clear or colorless. The solution's pH may be adjusted between 8.0-9.3 with Sodium Hydroxide and Hydrochloric Acid. It should be stored between 20-25°C (68-77°F) with short excursions to 15-30°C (59-86°F).*
Spl-image-07-10ml-25pk (Spl Image 07 10ml 25pk)
AIN00214 is a medication, specifically Furosemide which is provided in Injection form. Each mL of the injection contains 10 mg of Furosemide, Water for Injection, Sodium Chloride (for isotonicity), and Sodium Hydroxide. The pH of the solution is adjusted between 8 to 9.3 using Hydrochloric Acid (if needed). The package warning states that the unused portion of the medication should be discarded and the solution should be clear and colorless. The medication must be protected from light and stored at a temperature of 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The package insert contains the directions for use. The medication can be administered intravenously or intramuscularly, with a single dose of 10 mL viaL. The manufacturer of the medication is Baxter Healthcare Corporation, Deerfield, IL, USA.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
